← Back to Search

ICAD group for Stroke

N/A
Waitlist Available
Research Sponsored by Sohag University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up june 1st, 2025
Awards & highlights

Summary

Early identification of intracranial atherosclerotic disease (ICAD) may impact the management of patients undergoing mechanical thrombectomy (MT). The aim of the study is to develop and validate a scoring system for pre-thrombectomy diagnosis of ICAD in posterior circulation large vessel/distal medium vessel occlusion strokes (LVOs/DMVOs).

Eligible Conditions
  • Ischemic Stroke
  • Stroke
  • Intracranial Artery Stenosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~june 1st, 2025
This trial's timeline: 3 weeks for screening, Varies for treatment, and june 1st, 2025 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Post-procedural outcomes included any intracranial hemorrhage, symptomatic ICH (sICH)
Secondary study objectives
90 day modified Rankin scale (mRS)

Trial Design

2Treatment groups
Experimental Treatment
Group I: Non-ICAD cases (controls)Experimental Treatment1 Intervention
Non-ICAD cases (controls) includes patients with posterior circulation stroke attributed to stroke etiologies other than ICAD.
Group II: ICAD groupExperimental Treatment1 Intervention
includes ICAD-related stroke made when a smooth-bordered lesions leading to delayed perfusion on conventional-angiography (without competing stroke etiology) or when irregular-surfaced lesions involving the target vessel during mechanical thrombectomy were unveiled (with or without competing stroke etiology).

Find a Location

Who is running the clinical trial?

Sohag UniversityLead Sponsor
761 Previous Clinical Trials
91,632 Total Patients Enrolled
1 Trials studying Stroke
100 Patients Enrolled for Stroke
Emory UniversityOTHER
1,679 Previous Clinical Trials
2,583,516 Total Patients Enrolled
31 Trials studying Stroke
350,032 Patients Enrolled for Stroke
~100 spots leftby Jun 2025